Informacja

Drogi użytkowniku, aplikacja do prawidłowego działania wymaga obsługi JavaScript. Proszę włącz obsługę JavaScript w Twojej przeglądarce.

Wyszukujesz frazę ""biological therapy"" wg kryterium: Temat


Tytuł:
Translational Relevance of Advanced Age and Atherosclerosis in Preclinical Trials of Biotherapies for Peripheral Artery Disease.
Autorzy:
Webster KA; Vascular Biology Institute, University of Miami, Miami, FL 33146, USA.; Department of Ophthalmology, Baylor College of Medicine, Houston, TX 77030, USA.
Pokaż więcej
Źródło:
Genes [Genes (Basel)] 2024 Jan 22; Vol. 15 (1). Date of Electronic Publication: 2024 Jan 22.
Typ publikacji:
Journal Article; Review
MeSH Terms:
Biological Therapy*
Peripheral Arterial Disease*/complications
Peripheral Arterial Disease*/drug therapy
Adult ; Animals ; Humans ; Mice ; China ; Clinical Trials as Topic ; Ischemia/etiology ; Lower Extremity
Czasopismo naukowe
Tytuł:
Anti-IL23 biologic therapies in the treatment of psoriasis: real-world experience versus clinical trials data.
Autorzy:
Ruggiero A; Section of Dermatology - Department of Clinical Medicine and Surgery, University of Naples Federico II, Via Pansini 5, 80131, Naples, Italy. .
Megna M; Section of Dermatology - Department of Clinical Medicine and Surgery, University of Naples Federico II, Via Pansini 5, 80131, Naples, Italy.
Fabbrocini G; Section of Dermatology - Department of Clinical Medicine and Surgery, University of Naples Federico II, Via Pansini 5, 80131, Naples, Italy.
Ocampo-Garza SS; Section of Dermatology - Department of Clinical Medicine and Surgery, University of Naples Federico II, Via Pansini 5, 80131, Naples, Italy.; Dermatology Department, Universidad Autónoma de Nuevo León, University Hospital 'Dr, José Eleuterio González', Monterrey, NL, Mexico.
Pokaż więcej
Źródło:
Immunologic research [Immunol Res] 2023 Jun; Vol. 71 (3), pp. 328-355. Date of Electronic Publication: 2023 Jan 04.
Typ publikacji:
Journal Article; Review
MeSH Terms:
Biological Therapy*
Psoriasis*/drug therapy
Humans ; Interleukin-23 ; Treatment Outcome ; Severity of Illness Index
Czasopismo naukowe
Tytuł:
Antibody-guided proteases enable selective and catalytic degradation of challenging therapeutic targets.
Autorzy:
Romei MG; Department of Antibody Engineering, Genentech Inc, South San Francisco, California, USA. Electronic address: .
Leonard B; Department of Antibody Engineering, Genentech Inc, South San Francisco, California, USA.
Kim I; Department of Antibody Engineering, Genentech Inc, South San Francisco, California, USA.
Kim HS; Department of Antibody Engineering, Genentech Inc, South San Francisco, California, USA.
Lazar GA; Department of Antibody Engineering, Genentech Inc, South San Francisco, California, USA.
Pokaż więcej
Źródło:
The Journal of biological chemistry [J Biol Chem] 2023 May; Vol. 299 (5), pp. 104685. Date of Electronic Publication: 2023 Apr 07.
Typ publikacji:
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:
Antibodies, Monoclonal*
Endopeptidases*
Peptide Hydrolases*/metabolism
Biological Therapy*/methods
Immunoglobulin G
Czasopismo naukowe
Tytuł:
Impact of biological therapy in reducing the risk of arthritis development in inflammatory bowel diseases.
Autorzy:
Fatica M; Rheumatology, Department of Systems Medicine, University of Rome Tor Vergata, Rome, Italy.
Monosi B; Rheumatology, Department of Systems Medicine, University of Rome Tor Vergata, Rome, Italy.
Conigliaro P; Rheumatology, Department of Systems Medicine, University of Rome Tor Vergata, Rome, Italy.
D'Antonio A; Rheumatology, Department of Systems Medicine, University of Rome Tor Vergata, Rome, Italy.
Essofi S; Gastrointestinal Unit, Departement of Systems Medicine, University of Rome Tor Vergata, Rome, Italy.
Cuccagna E; Gastrointestinal Unit, Departement of Systems Medicine, University of Rome Tor Vergata, Rome, Italy.
Bergamini A; Rheumatology, Department of Systems Medicine, University of Rome Tor Vergata, Rome, Italy.
Biancone L; Gastrointestinal Unit, Departement of Systems Medicine, University of Rome Tor Vergata, Rome, Italy.
Monteleone G; Gastrointestinal Unit, Departement of Systems Medicine, University of Rome Tor Vergata, Rome, Italy.
Triggianese P; Rheumatology, Department of Systems Medicine, University of Rome Tor Vergata, Rome, Italy.
Calabrese E; Gastrointestinal Unit, Departement of Systems Medicine, University of Rome Tor Vergata, Rome, Italy.
Chimenti MS; Rheumatology, Department of Systems Medicine, University of Rome Tor Vergata, Rome, Italy .
Pokaż więcej
Źródło:
RMD open [RMD Open] 2024 Jan 31; Vol. 10 (1). Date of Electronic Publication: 2024 Jan 31.
Typ publikacji:
Journal Article
MeSH Terms:
Antirheumatic Agents*/adverse effects
Inflammatory Bowel Diseases*/complications
Inflammatory Bowel Diseases*/drug therapy
Spondylarthritis*/complications
Spondylarthritis*/drug therapy
Spondylarthritis*/epidemiology
Psoriasis*/epidemiology
Female ; Humans ; Retrospective Studies ; Biological Therapy/adverse effects
Czasopismo naukowe
Tytuł:
Adalimumab-induced optic neuritis: A rare side effect of biological therapy.
Autorzy:
Bardazzi F; Dermatology Unit - IRCCS, Azienda Ospedaliero-Universitaria, Policlinico Sant'Orsola-Malpighi, Bologna, Italy.
Filippi F; Dermatology Unit - IRCCS, Azienda Ospedaliero-Universitaria, Policlinico Sant'Orsola-Malpighi, Bologna, Italy.
Pagliara A; Dermatology Unit - IRCCS, Azienda Ospedaliero-Universitaria, Policlinico Sant'Orsola-Malpighi, Bologna, Italy.; Department of Medical and Surgical Sciences, Alma Mater Studiorum, University of Bologna, Bologna, Italy.
Clarizio G; Dermatology Unit - IRCCS, Azienda Ospedaliero-Universitaria, Policlinico Sant'Orsola-Malpighi, Bologna, Italy.; Department of Medical and Surgical Sciences, Alma Mater Studiorum, University of Bologna, Bologna, Italy.
Loi C; Dermatology Unit - IRCCS, Azienda Ospedaliero-Universitaria, Policlinico Sant'Orsola-Malpighi, Bologna, Italy.
Sacchelli L; Dermatology Unit - IRCCS, Azienda Ospedaliero-Universitaria, Policlinico Sant'Orsola-Malpighi, Bologna, Italy.
La Placa M; Dermatology Unit - IRCCS, Azienda Ospedaliero-Universitaria, Policlinico Sant'Orsola-Malpighi, Bologna, Italy.; Department of Medical and Surgical Sciences, Alma Mater Studiorum, University of Bologna, Bologna, Italy.
Pokaż więcej
Źródło:
International journal of dermatology [Int J Dermatol] 2024 Mar; Vol. 63 (3), pp. e79-e80. Date of Electronic Publication: 2024 Jan 16.
Typ publikacji:
Letter
MeSH Terms:
Optic Neuritis*/chemically induced
Optic Neuritis*/drug therapy
Humans ; Adalimumab/adverse effects ; Antibodies, Monoclonal/adverse effects ; Biological Therapy
Opinia redakcyjna
Tytuł:
Responsiveness of the Colombian Spanish Version of the DLQI in Psoriasis Patients With Biologic Therapy.
Autorzy:
Tibaduiza MF; Grupo de Investigacion Dermatologica (GRID), Facultad de Medicina, Universidad de Antioquia, Medellín, Colombia.
Berbeo YK; Grupo de Investigacion Dermatologica (GRID), Facultad de Medicina, Universidad de Antioquia, Medellín, Colombia.
Ton CM; Facultad de Medicina, Universidad de Antioquia, Medellín, Colombia.
Aguirre-Acevedo DC; Grupo de Investigacion Dermatologica (GRID), Facultad de Medicina, Universidad de Antioquia, Medellín, Colombia.
Sanclemente G; Grupo de Investigacion Dermatologica (GRID), Facultad de Medicina, Universidad de Antioquia, Medellín, Colombia; Hospital San Vicente Fundación, Medellín, Colombia; Hospital Alma Máter de Antioquía, IPS Universitaria, Universidad de Antioquía, Medellín, Colombia. Electronic address: .
Pokaż więcej
Transliterated Title:
[Artículo traducido] Capacidad de respuesta de la versión en español colombiano del DLQI en pacientes con psoriasis en terapia biológica.
Źródło:
Actas dermo-sifiliograficas [Actas Dermosifiliogr] 2024 Mar; Vol. 115 (3), pp. T316-T320. Date of Electronic Publication: 2024 Jan 04.
Typ publikacji:
Case Reports
MeSH Terms:
Psoriasis*/drug therapy
Humans ; Colombia ; Quality of Life ; Biological Therapy ; Severity of Illness Index ; Treatment Outcome
Raport
Tytuł:
Multi-failure psoriasis patients: characterization of the patients and response to biological therapy in a multicenter Italian cohort.
Autorzy:
Viola R; Section of Dermatology and Venereology, Department of Precision and Regenerative Medicine and Ionian Area (DiMePRe-J), University of Bari 'Aldo Moro', Bari, Italy.
Mastorino L; Department of Medical Sciences, Dermatology Clinic, University of Turin, Turin, Italy.
Megna M; Section of Dermatology, Department of Clinical Medicine and Surgery, University of Naples Federico II, Naples, Italy.
Damiani G; Clinical Dermatology, I.R.C.C.S. Istituto Ortopedico Galeazzi, Milan, Italy.
Gisondi P; Department of Medicine, Section of Dermatology and Venereology, University of Verona, Verona, Italy.
Argenziano G; Dermatology Unit, University of Campania L. Vanvitelli, Naples, Italy.
Peris K; Institute of Dermatology, Università Cattolica-Fondazione Policlinico Universitario A. Gemelli IRCCS, Rome, Italy.
Prignano F; Section of Dermatology, Department of Health Sciences, University of Florence, Florence, Italy.
Burlando M; Section of Dermatology, Department of Health Sciences (DISSAL), IRCCS San Martino University Hospital, Genoa, Italy.
Conti A; Dermatologic Unit, Department of Surgery, Infermi Hospital, AUSL Romagna, Rimini, Italy.
Loconsole F; Section of Dermatology and Venereology, Department of Precision and Regenerative Medicine and Ionian Area (DiMePRe-J), University of Bari 'Aldo Moro', Bari, Italy.
Malagoli P; Department of Dermatology, Dermatology Unit Azienda Ospedaliera San Donato Milanese, Milan, Italy.
Zalaudek I; Department of Dermatology and Venereology, Dermatology Clinic, Maggiore Hospital, University of Trieste, Trieste, Italy.
Cacciapuoti S; Section of Dermatology, Department of Clinical Medicine and Surgery, University of Naples Federico II, Naples, Italy.
Bellinato F; Department of Medicine, Section of Dermatology and Venereology, University of Verona, Verona, Italy.
Balato A; Dermatology Unit, University of Campania L. Vanvitelli, Naples, Italy.
De Simone C; Institute of Dermatology, Università Cattolica-Fondazione Policlinico Universitario A. Gemelli IRCCS, Rome, Italy.
Chersi K; Department of Dermatology and Venereology, Dermatology Clinic, Maggiore Hospital, University of Trieste, Trieste, Italy.
Ortoncelli M; Department of Medical Sciences, Dermatology Clinic, University of Turin, Turin, Italy.
Quaglino P; Department of Medical Sciences, Dermatology Clinic, University of Turin, Turin, Italy.
Dapavo P; Department of Medical Sciences, Dermatology Clinic, University of Turin, Turin, Italy.
Ribero S; Department of Medical Sciences, Dermatology Clinic, University of Turin, Turin, Italy.
Pokaż więcej
Źródło:
International journal of dermatology [Int J Dermatol] 2024 Mar; Vol. 63 (3), pp. 351-358. Date of Electronic Publication: 2024 Jan 05.
Typ publikacji:
Multicenter Study; Journal Article
MeSH Terms:
Psoriasis*/drug therapy
Biological Products*/therapeutic use
Humans ; Treatment Outcome ; Biological Factors/therapeutic use ; Biological Therapy ; Interleukin-23/therapeutic use ; Italy/epidemiology ; Severity of Illness Index
Czasopismo naukowe
Tytuł:
PsoBioVax: A multicentric Italian case-control study of the immunological response to anti-SARS-CoV-2 vaccine among psoriatic patients under biological therapy.
Autorzy:
Sacchelli L; Dermatology Unit, IRCCS Azienda Ospedaliero-Universitaria di Bologna, Policlinico S. Orsola-Malpighi, Bologna, Italy.; Department of Medical and Surgical Sciences, Alma Mater Studiorum, University of Bologna, Bologna, Italy.
Filippi F; Dermatology Unit, IRCCS Azienda Ospedaliero-Universitaria di Bologna, Policlinico S. Orsola-Malpighi, Bologna, Italy.; Department of Medical and Surgical Sciences, Alma Mater Studiorum, University of Bologna, Bologna, Italy.
Balato A; Unit of Dermatology, University of Campania Luigi Vanvitelli, Naples, Italy.
Balestri R; Division of Dermatology, Psoriasis Outpatient Service, APSS, Trento, Italy.
Bellinato F; Dipartimento di Medicina Sezione Di Dermatologia Università di Verona, Verona, Italy.
Bernardini N; Department of Medico-Surgical Sciences and Biotechnologies Faculty of Pharmacy and Medicine Sapienza University of Rome - Polo Pontino (ASL Latina), Latina, Italy.
Bianchi L; Dermatology, University of Rome Tor Vergata, Rome, Italy.
Burlando M; Department of Dermatology, DISSAL University of Genoa, IRCCS Ospedale Policlinico San Martino, Genova, Italy.
Campanati A; Dermatological Clinic, Department of Clinical and Molecular Sciences, Polytechnic Marche University, Ancona, Italy.
Chessa MA; Dermatology Unit, IRCCS Azienda Ospedaliero-Universitaria di Bologna, Policlinico S. Orsola-Malpighi, Bologna, Italy.; Department of Medical and Surgical Sciences, Alma Mater Studiorum, University of Bologna, Bologna, Italy.
Corazza M; Department of Medical Sciences, Section of Dermatology and Infectious Diseases, University of Ferrara, Ferrara, Italy.
Di Cesare A; Department of Health Sciences, Section of Dermatology, University of Florence, Florence, Italy.
Di Lernia V; Dermatology Unit, Arcispedale Santa Maria Nuova, Azienda USL-IRCCS di Reggio Emilia, Reggio Emilia, Italy.
Diotallevi F; Dermatological Clinic, Department of Clinical and Molecular Sciences, Polytechnic Marche University, Ancona, Italy.
Esposito M; Biotechnological and Applied Clinical Sciences, University of L'Aquila, L'Aquila, Italy.; Dermatology Unit, Ospedale San Salvatore, L'Aquila, Italy.
Fargnoli MC; Biotechnological and Applied Clinical Sciences, University of L'Aquila, L'Aquila, Italy.; Dermatology Unit, Ospedale San Salvatore, L'Aquila, Italy.
Gisondi P; Dipartimento di Medicina Sezione Di Dermatologia Università di Verona, Verona, Italy.
Giunta A; Dermatology, Fondazione PTV Policlinico Tor Vergata, Rome, Italy.
Hansel K; Dermatology Section, Department of Medicine and Surgery, University of Perugia, Perugia, Italy.
Magnano M; Division of Dermatology, Psoriasis Outpatient Service, APSS, Trento, Italy.
Megna M; Section of Dermatology, Department of Clinical Medicine and Surgery, University of Naples Federico II, Napoli, Italy.
Odorici G; Department of Medical Sciences, Section of Dermatology and Infectious Diseases, University of Ferrara, Ferrara, Italy.
Prignano F; Department of Health Sciences, Section of Dermatology, University of Florence, Florence, Italy.
Potenza C; Department of Medico-Surgical Sciences and Biotechnologies Faculty of Pharmacy and Medicine Sapienza University of Rome - Polo Pontino (ASL Latina), Latina, Italy.
Rech G; Division of Dermatology, Psoriasis Outpatient Service, APSS, Trento, Italy.
Rovesti M; Dermatologic Unit, Ospedale 'Guglielmo da Saliceto', Piacenza, PC, Italy.
Ruggiero A; Section of Dermatology, Department of Clinical Medicine and Surgery, University of Naples Federico II, Napoli, Italy.
Satolli F; UOC Dermatologia, University of Parma, Parma, Italy.
Stingeni L; Dermatology Section, Department of Medicine and Surgery, University of Perugia, Perugia, Italy.
Gibertoni D; Research and Innovation Unit, IRCCS Azienda Ospedaliero-Universitaria di Bologna, Bologna, Italy.
Bardazzi F; Dermatology Unit, IRCCS Azienda Ospedaliero-Universitaria di Bologna, Policlinico S. Orsola-Malpighi, Bologna, Italy.; Department of Medical and Surgical Sciences, Alma Mater Studiorum, University of Bologna, Bologna, Italy.
Pokaż więcej
Źródło:
Journal of the European Academy of Dermatology and Venereology : JEADV [J Eur Acad Dermatol Venereol] 2024 Mar; Vol. 38 (3), pp. e215-e218. Date of Electronic Publication: 2023 Dec 07.
Typ publikacji:
Letter
MeSH Terms:
COVID-19 Vaccines*/therapeutic use
COVID-19*/prevention & control
Humans ; Case-Control Studies ; Biological Therapy ; Italy
Opinia redakcyjna
Tytuł:
Impact of the time of initiation and line of biologic therapy on the retention rate of secukinumab in axial spondyloarthritis (axSpA): data from the French multicentre retrospective FORSYA study.
Autorzy:
Dougados M; Hopital Cochin, Rheumatology, Université Paris Descartes Faculté de Médecine, Paris, France .
Lardy-Cléaud A; Biostatistics RCTs Clinical Research Organization, Lyon, France.
Desfleurs E; Novartis Pharma France, Rueil Malmaison, France.
Claudepierre P; Rheumatology, Hôpital Henri Mondor, Créteil, France.; EA EpidermE, Université Paris Est Créteil, Créteil, France.
Goupille P; Rheumatology, CHU Tours, TOURS, France.
Ryussen-Witrand A; Rheumatology, CHU Purpan, Toulouse, France.; UMR1027, INSERM/UPS Toulouse III, Toulouse, France.
Saraux A; Université de Bretagne Occidentale (Univ Brest), Brest, France.
Tournadre A; Centre Hospitalier Universitaire de Clermont-Ferrand, Clermont-Ferrand, France.
Wendling D; Rheumatology, CHU J Minjoz, Besancon, France.
Lukas C; Rheumatology, University Hospital Lapeyronie, Montpellier, France.; EA2415, Montpellier University, Montpellier, France.
Pokaż więcej
Źródło:
RMD open [RMD Open] 2024 Feb 29; Vol. 10 (1). Date of Electronic Publication: 2024 Feb 29.
Typ publikacji:
Multicenter Study; Journal Article
MeSH Terms:
Spondylitis, Ankylosing*
Axial Spondyloarthritis*
Antibodies, Monoclonal, Humanized*
Humans ; Retrospective Studies ; Treatment Outcome ; Biological Therapy
Czasopismo naukowe
Tytuł:
A sprinkle of methotrexate to go with biologics: a safe recipe?
Autorzy:
Alabas OA; Division of Musculoskeletal and Dermatological Sciences, School of Biological Sciences, Faculty of Biology, Medicine and Health, The University of Manchester.
Yiu ZZN; Division of Musculoskeletal and Dermatological Sciences, School of Biological Sciences, Faculty of Biology, Medicine and Health, The University of Manchester.; Dermatology Department, Salford Royal Hospital, Northern Care Alliance NHS Foundation Trust, Manchester Academic Health Science Centre, Manchester, UK.
Pokaż więcej
Źródło:
The British journal of dermatology [Br J Dermatol] 2024 Feb 16; Vol. 190 (3), pp. 302-303.
Typ publikacji:
Editorial; Comment
MeSH Terms:
Biological Products*/adverse effects
Psoriasis*/drug therapy
Humans ; Methotrexate/adverse effects ; Cohort Studies ; Biological Factors ; Biological Therapy
Opinia redakcyjna
Tytuł:
Safety of biologic therapy in combination with methotrexate in moderate to severe psoriasis: a cohort study from the BIOBADADERM registry.
Autorzy:
Lluch-Galcerá JJ; Department of Dermatology, Hospital Universitari Germans Trias i Pujol, Universitat Autònoma de Barcelona, IGTP. Badalona, Barcelona, Spain.; Departament de Medicina, Universitat Autonoma de Barcelona (UAB), Barcelona, Spain.
Carrascosa JM; Department of Dermatology, Hospital Universitari Germans Trias i Pujol, Universitat Autònoma de Barcelona, IGTP. Badalona, Barcelona, Spain.; Departament de Medicina, Universitat Autonoma de Barcelona (UAB), Barcelona, Spain.
González-Quesada A; Department of Dermatology, Hospital Universitario de Gran Canaria Dr. Negrín, Las Palmas de Gran Canaria, Islas Canarias, Spain.
Rivera-Díaz R; Department of Dermatology, Hospital Universitario 12 de Octubre, Universidad Complutense, Madrid, Spain.
Sahuquillo-Torralba A; Department of Dermatology, Hospital Universitario y Politécnico La Fe, Valencia,Spain.
Llamas-Velasco M; Department of Dermatology, Hospital Universitario de La Princesa, Instituto de Investigación Sanitaria de La Princesa (IIS-LP), Madrid,Spain.
Gómez-García FJ; Department of Dermatology, Hospital Universitario Reina Sofía, Córdoba, Spain.
Herrera-Acosta E; Department of Dermatology, Hospital Universitario Virgen de la Victoria, Málaga, Spain.
de la Cueva P; Department of Dermatology, Hospital Universitario Infanta Leonor, Madrid, Spain.
Baniandrés-Rodríguez O; Department of Dermatology, CEIMI, Hospital General Universitario Gregorio Marañón, Madrid, Spain.
Lopez-Estebaranz JL; Department of Dermatology, Hospital Universitario Fundación Alcorcón, Alcorcón, Madrid, Spain.
Belinchón I; Department of Dermatology, Hospital General Universitario de Alicante-ISABIAL-UMH, Alicante, Spain.
Ferrán M; Department of Dermatology, Hospital del Mar, Parc de Salut Mar, Barcelona, Spain.
Mateu A; Department of Dermatology, Hospital Universitario Doctor Peset, Valencia, Spain.
Rodríguez L; Department of Dermatology, Hospital Virgen del Rocío, Seville, Spain.
Riera-Monroig J; Department of Dermatology, Hospital Clinic de Barcelona, UB, Barcelona, Spain.
Abalde-Pintos MT; Department of Dermatology, Complejo Hospitalario Universitario de Pontevedra, Pontevedra, Spain.
Carretero G; Department of Dermatology, Hospital Universitario de Gran Canaria Dr. Negrín, Las Palmas de Gran Canaria, Islas Canarias, Spain.
García-Donoso C; Department of Dermatology, Hospital Universitario 12 de Octubre, Universidad Complutense, Madrid, Spain.
Pujol-Marco C; Department of Dermatology, Hospital Universitario y Politécnico La Fe, Valencia,Spain.
Del Alcázar E; Department of Dermatology, Hospital Universitari Germans Trias i Pujol, Universitat Autònoma de Barcelona, IGTP. Badalona, Barcelona, Spain.; Departament de Medicina, Universitat Autonoma de Barcelona (UAB), Barcelona, Spain.
Santamaría-Domínguez C; Department of Dermatology, Hospital Universitario de La Princesa, Instituto de Investigación Sanitaria de La Princesa (IIS-LP), Madrid,Spain.
Suárez-Pérez JA; Department of Dermatology, Hospital Universitario Virgen de la Victoria, Málaga, Spain.
Nieto-Benito LM; Department of Dermatology, CEIMI, Hospital General Universitario Gregorio Marañón, Madrid, Spain.
Ruiz-Genao DP; Department of Dermatology, Hospital Universitario Fundación Alcorcón, Alcorcón, Madrid, Spain.
Salgado-Boquete L; Department of Dermatology, Complejo Hospitalario Universitario de Pontevedra, Pontevedra, Spain.
Descalzo MÁ; Research Unit, Spanish Academy of Dermatology and Venereology, Madrid, Spain.
García-Doval I; Research Unit, Spanish Academy of Dermatology and Venereology, Madrid, Spain.; Department of Dermatology, Complexo Hospitalario Universitario de Vigo, Vigo, Pontevedra, Spain.
Pokaż więcej
Źródło:
The British journal of dermatology [Br J Dermatol] 2024 Feb 16; Vol. 190 (3), pp. 355-363.
Typ publikacji:
Journal Article
MeSH Terms:
Psoriasis*/pathology
Biological Products*/adverse effects
Humans ; Methotrexate ; Cohort Studies ; Registries ; Biological Therapy
Czasopismo naukowe
Tytuł:
From biomaterials to biotherapy: cuttlefish ink with protoporphyrin IX nanoconjugates for synergistic sonodynamic-photothermal therapy.
Autorzy:
Li Y; College of Materials and Chemical Engineering, China Three Gorges University, Yichang 443002, China. .
Huang L; College of Basic Medical Science, China Three Gorges University, Yichang 443002, China.
Li X; Hubei Key Laboratory of Tumor Microenvironment and Immunotherapy, China Three Gorges University, Yichang 443002, China.
Geng P; College of Materials and Chemical Engineering, China Three Gorges University, Yichang 443002, China. .; Hubei Key Laboratory of Tumor Microenvironment and Immunotherapy, China Three Gorges University, Yichang 443002, China.
Xiang J; College of Materials and Chemical Engineering, China Three Gorges University, Yichang 443002, China. .
Wang W; College of Materials and Chemical Engineering, China Three Gorges University, Yichang 443002, China. .
Yang B; College of Materials and Chemical Engineering, China Three Gorges University, Yichang 443002, China. .
Zheng Y; College of Materials and Chemical Engineering, China Three Gorges University, Yichang 443002, China. .
Lan H; College of Materials and Chemical Engineering, China Three Gorges University, Yichang 443002, China. .
Xiao S; College of Materials and Chemical Engineering, China Three Gorges University, Yichang 443002, China. .
Pokaż więcej
Źródło:
Journal of materials chemistry. B [J Mater Chem B] 2024 Feb 14; Vol. 12 (7), pp. 1837-1845. Date of Electronic Publication: 2024 Feb 14.
Typ publikacji:
Journal Article
MeSH Terms:
Ultrasonic Therapy*
Neoplasms*/therapy
Protoporphyrins*
Animals ; Mice ; Nanoconjugates ; Ink ; Photothermal Therapy ; Biological Therapy
Czasopismo naukowe
Tytuł:
Biological therapy for inflammatory bowel disease: cyclical rather than lifelong treatment?
Autorzy:
Selinger CP; Gastroenterology, Leeds Teaching Hospitals NHS Trust, Leeds, UK .
Rosiou K; Department of Gastroenterology, St James's University Hospital, Leeds, UK.
Lenti MV; Internal Medicine, Fondazione IRCCS Policlinico San Matteo, Pavia, Italy.
Pokaż więcej
Źródło:
BMJ open gastroenterology [BMJ Open Gastroenterol] 2024 Feb 10; Vol. 11 (1). Date of Electronic Publication: 2024 Feb 10.
Typ publikacji:
Journal Article; Review
MeSH Terms:
Colitis, Ulcerative*/drug therapy
Crohn Disease*/drug therapy
Inflammatory Bowel Diseases*/drug therapy
Humans ; Tumor Necrosis Factor-alpha/therapeutic use ; Biological Therapy ; Recurrence
Czasopismo naukowe
Tytuł:
Major cardiovascular events under biologic psoriasis therapies: a 19-year real-world analysis of FAERS data.
Autorzy:
Ding L; Department of Pharmacy, Xiamen Cardiovascular Hospital, Xiamen University, Xiamen, China.
Chen C; Department of Pharmacy, Xiamen Cardiovascular Hospital, Xiamen University, Xiamen, China.
Yang Y; School of Electrical Engineering and Automation, Xiamen University of Technology, Xiamen, China.
Zhang X; Department of Pharmacy, Xiamen Cardiovascular Hospital, Xiamen University, Xiamen, China.
Pokaż więcej
Źródło:
Frontiers in immunology [Front Immunol] 2024 Feb 07; Vol. 15, pp. 1349636. Date of Electronic Publication: 2024 Feb 07 (Print Publication: 2024).
Typ publikacji:
Journal Article
MeSH Terms:
Stroke*
Psoriasis*/drug therapy
Biological Products*/adverse effects
United States ; Humans ; Interleukin-17 ; United States Food and Drug Administration ; Tumor Necrosis Factor Inhibitors/therapeutic use ; Biological Therapy ; Interleukin-12 ; Interleukin-23
Czasopismo naukowe
Tytuł:
Transition from intravenous to subcutaneous biological therapies in inflammatory bowel disease: An online survey of patients.
Autorzy:
Napolitano D; CEMAD Digestive Disease Center, Fondazione Policlinico Universitario 'A. Gemelli' IRCCS, Università Cattolica del Sacro Cuore, 00168, Rome, Italy. .
Settanni CR; UOSD Gastroenterologia ed Endoscopia Digestiva, IRCCS INRCA, 60127, Ancona, Italy.
Parisio L; CEMAD Digestive Disease Center, Fondazione Policlinico Universitario 'A. Gemelli' IRCCS, Università Cattolica del Sacro Cuore, 00168, Rome, Italy.
Orgiana N; Fondazione Policlinico A. Gemelli IRCCS, 00168, Rome, Italy.
Poscia A; Fondazione Policlinico A. Gemelli IRCCS, 00168, Rome, Italy.
Schiavoni E; CEMAD Digestive Disease Center, Fondazione Policlinico Universitario 'A. Gemelli' IRCCS, Università Cattolica del Sacro Cuore, 00168, Rome, Italy.
Turchini L; CEMAD Digestive Disease Center, Fondazione Policlinico Universitario 'A. Gemelli' IRCCS, Università Cattolica del Sacro Cuore, 00168, Rome, Italy.
Cascio AL; La Maddalena Cancer Center, Palermo, Italy.
Germini F; ASL Bari, Bari, Italy.
Sblendorio E; Azienda Ospedaliero-Universitaria Consorziale Policlinico di Bari, Bari, Italy.
Milani A; Istituto Europeo di Oncologia, Milan, Italy.
Patteril C; Università Cattolica del Sacro Cuore, Rome, Italy.
Laterza L; CEMAD Digestive Disease Center, Fondazione Policlinico Universitario 'A. Gemelli' IRCCS, Università Cattolica del Sacro Cuore, 00168, Rome, Italy.
Lopetuso LR; CEMAD Digestive Disease Center, Fondazione Policlinico Universitario 'A. Gemelli' IRCCS, Università Cattolica del Sacro Cuore, 00168, Rome, Italy.
Pugliese D; CEMAD Digestive Disease Center, Fondazione Policlinico Universitario 'A. Gemelli' IRCCS, Università Cattolica del Sacro Cuore, 00168, Rome, Italy.
Papa A; CEMAD Digestive Disease Center, Fondazione Policlinico Universitario 'A. Gemelli' IRCCS, Università Cattolica del Sacro Cuore, 00168, Rome, Italy.
Gasbarrini A; CEMAD Digestive Disease Center, Fondazione Policlinico Universitario 'A. Gemelli' IRCCS, Università Cattolica del Sacro Cuore, 00168, Rome, Italy.
Scaldaferri F; CEMAD Digestive Disease Center, Fondazione Policlinico Universitario 'A. Gemelli' IRCCS, Università Cattolica del Sacro Cuore, 00168, Rome, Italy.
Pokaż więcej
Źródło:
Indian journal of gastroenterology : official journal of the Indian Society of Gastroenterology [Indian J Gastroenterol] 2024 Feb; Vol. 43 (1), pp. 215-225. Date of Electronic Publication: 2024 Jan 20.
Typ publikacji:
Journal Article
MeSH Terms:
Crohn Disease*/drug therapy
Inflammatory Bowel Diseases*/drug therapy
Colitis, Ulcerative*/drug therapy
Humans ; Surveys and Questionnaires ; Administration, Intravenous ; Biological Therapy
Czasopismo naukowe
Tytuł:
The Impact of Biologic Therapies on Rate of Colectomy in Paediatric-onset Ulcerative Colitis - A Population-Based Cohort Study.
Autorzy:
Hope E; Department of Paediatric Surgery, Royal Hospital for Children and Young People, Edinburgh, 50 Little France Crescent, Edinburgh, EH16 4TJ, UK.
Kuronen-Stewart C; Department of Paediatric Surgery, Royal Hospital for Children and Young People, Edinburgh, 50 Little France Crescent, Edinburgh, EH16 4TJ, UK. Electronic address: .
Wilson DC; Department of Paediatric Gastroenterology and Nutrition, Royal Hospital for Children and Young People, Edinburgh, 50 Little France Crescent, Edinburgh, EH16 4TJ, UK; Department of Child Life and Health, University of Edinburgh, 50 Little France Crescent, Edinburgh, EH16 4TJ, UK.
Henderson P; Department of Paediatric Gastroenterology and Nutrition, Royal Hospital for Children and Young People, Edinburgh, 50 Little France Crescent, Edinburgh, EH16 4TJ, UK; Department of Child Life and Health, University of Edinburgh, 50 Little France Crescent, Edinburgh, EH16 4TJ, UK.
Clark C; Department of Paediatric Surgery, Royal Hospital for Children and Young People, Edinburgh, 50 Little France Crescent, Edinburgh, EH16 4TJ, UK.
Pokaż więcej
Źródło:
Journal of pediatric surgery [J Pediatr Surg] 2024 Feb; Vol. 59 (2), pp. 230-234. Date of Electronic Publication: 2023 Oct 21.
Typ publikacji:
Journal Article
MeSH Terms:
Colitis, Ulcerative*/drug therapy
Colitis, Ulcerative*/surgery
Biological Products*/therapeutic use
Adult ; Child ; Humans ; Cohort Studies ; Colectomy ; Biological Therapy
SCR Disease Name:
Pediatric ulcerative colitis
Czasopismo naukowe
Tytuł:
Drug survival of biologic therapies for palmoplantar pustulosis: A nationwide study.
Autorzy:
Bertelsen T; Department of Dermatology, Aarhus University Hospital, Aarhus, Denmark.; DERMBIO, Denmark.
Egeberg A; DERMBIO, Denmark.; Department of Dermatology, Bispebjerg Hospital, University of Copenhagen, Copenhagen, Denmark.; Department of Clinical Medicine, University of Copenhagen, Copenhagen, Denmark.
Skov L; DERMBIO, Denmark.; Department of Clinical Medicine, University of Copenhagen, Copenhagen, Denmark.; Department of Dermatology and Allergy, Herlev and Gentofte Hospital, Hellerup, Denmark.
Rasmussen M; Department of Dermatology, Aarhus University Hospital, Aarhus, Denmark.; DERMBIO, Denmark.
Bryld L; DERMBIO, Denmark.; Department of Dermatology, Roskilde Hospital, Roskilde, Denmark.
Funding A; DERMBIO, Denmark.; Dermatology Clinic, Hudcenter Nord, Aalborg, Denmark.
Ajgeiy K; DERMBIO, Denmark.; Department of Dermatology, Odense University Hospital, Odense, Denmark.
Thein D; Department of Dermatology, Bispebjerg Hospital, University of Copenhagen, Copenhagen, Denmark.
Pokaż więcej
Źródło:
Journal of the European Academy of Dermatology and Venereology : JEADV [J Eur Acad Dermatol Venereol] 2024 Feb; Vol. 38 (2), pp. 332-339. Date of Electronic Publication: 2023 Nov 17.
Typ publikacji:
Journal Article
MeSH Terms:
Psoriasis*/drug therapy
Psoriasis*/chemically induced
Biological Products*/therapeutic use
Humans ; Ustekinumab/therapeutic use ; Ustekinumab/adverse effects ; Adalimumab/adverse effects ; Prospective Studies ; Biological Factors/therapeutic use ; Biological Therapy ; Treatment Outcome
Czasopismo naukowe
Tytuł:
The New Therapeutic Frontiers in the Treatment of Eosinophilic Esophagitis: Biological Drugs.
Autorzy:
Ridolo E; Department of Medicine and Surgery, University of Parma, 43121 Parma, Italy.
Barone A; Department of Medicine and Surgery, University of Parma, 43121 Parma, Italy.
Ottoni M; Department of Medicine and Surgery, University of Parma, 43121 Parma, Italy.
Peveri S; Departmental Unit of Allergology, Guglielmo da Saliceto Hospital, 29121 Piacenza, Italy.
Montagni M; Departmental Unit of Allergology, Guglielmo da Saliceto Hospital, 29121 Piacenza, Italy.
Nicoletta F; Department of Medicine and Surgery, University of Parma, 43121 Parma, Italy.
Pokaż więcej
Źródło:
International journal of molecular sciences [Int J Mol Sci] 2024 Jan 30; Vol. 25 (3). Date of Electronic Publication: 2024 Jan 30.
Typ publikacji:
Journal Article; Review
MeSH Terms:
Eosinophilic Esophagitis*/drug therapy
Biological Products*/therapeutic use
Enteritis*
Eosinophilia*
Gastritis*
Humans ; Biological Therapy ; Biological Factors/therapeutic use
SCR Disease Name:
Eosinophilic enteropathy
Czasopismo naukowe

Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies